KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Revenue: 2015-2025

Historic Revenue for Medpace Holdings (MEDP) over the last 10 years, with Sep 2025 value amounting to $659.9 million.

  • Medpace Holdings' Revenue rose 23.74% to $659.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 billion, marking a year-over-year increase of 13.88%. This contributed to the annual value of $2.1 billion for FY2024, which is 11.84% up from last year.
  • Latest data reveals that Medpace Holdings reported Revenue of $659.9 million as of Q3 2025, which was up 9.38% from $603.3 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Revenue ranged from a high of $659.9 million in Q3 2025 and a low of $260.0 million during Q1 2021.
  • Moreover, its 3-year median value for Revenue was $528.1 million (2024), whereas its average is $528.8 million.
  • Data for Medpace Holdings' Revenue shows a peak YoY skyrocketed of 35.76% (in 2021) over the last 5 years.
  • Medpace Holdings' Revenue (Quarterly) stood at $308.6 million in 2021, then grew by 27.72% to $394.1 million in 2022, then rose by 26.47% to $498.4 million in 2023, then increased by 7.66% to $536.6 million in 2024, then rose by 23.74% to $659.9 million in 2025.
  • Its Revenue was $659.9 million in Q3 2025, compared to $603.3 million in Q2 2025 and $558.6 million in Q1 2025.